The revised guidelines stress the use of high-quality imaging and consistency in images taken.

People with MS who have comorbidities may be more likely to experience disruptive pain.

Another study suggests that a telehealth system could help objectively monitor dose adherence.

Rates were similar, but gender and age-specific differences emerged.

Insurance coverage can be the determining factor on whether a patient receives DMT or not.

A team to address both the physical and emotional outcomes of MS relapse is essential to high quality care.

A combination of physical, occupational, hand, speech, cognitive, and behavioral therapy improves outcomes.